Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer.

Pharmacogenetics - 1 Jun 1999

Wadelius M, Autrup J L, Stubbins M J, Andersson S O, Johansson J E, Wadelius C, Wolf C R, Autrup H, Rane A

Abstract excerpt

The development of prostate cancer is dependent on heredity, androgenic influences, and exposure to environmental agents. A high intake of dietary fat is associated with an increased risk of prostate cancer, either through influence on steroid hormone profiles or through production of carcinogeni...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Aryl Hydrocarbon Hydroxylases
Share to Arylamine N-Acetyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Cytochrome P-450 CYP2D6

Share to Cytochrome P-450 Enzyme System

Share to Glutathione S-Transferase pi

Share to Mixed Function Oxygenases

Source

Identifiers

PMID: 10471065
DOI: 10.1097/00008571-199906000-00008

Genes

GSTP1
NAT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10471065-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer.PMID 10471065Read ↗

A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.Semantic proximity Read ↗

Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer.Semantic proximity Read ↗

Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk.Semantic proximity Read ↗

CYP17, SRD5A2, CYP1B1, and CYP2D6 gene polymorphisms with prostate cancer risk in North Indian population.Semantic proximity Read ↗

Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.Semantic proximity Read ↗

Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.Semantic proximity Read ↗

Gender-specific effects of NAT2 and GSTM1 in bladder cancer.Semantic proximity Read ↗

Genetic polymorphism and cancer risk.Semantic proximity Read ↗

Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer.Semantic proximity Read ↗

MnSOD genotype and prostate cancer risk as a function of NAT genotype and smoking status.Semantic proximity Read ↗

Association of NAT2, GSTT1, and GSTM1 gene polymorphisms withprostate cancer risk in Bangladeshi population.Semantic proximity Read ↗

Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.